Education
About Us
Working with TipRanks
Follow Us
Comera Life Sciences Holdings (CMRA)
OTHER OTC:CMRA
Total Valuation
Comera Life Sciences Holdings has a market cap or net worth of $6.15K. The enterprise value is ―.
Market Cap$6.15K
Enterprise Value―
Share Statistics
Comera Life Sciences Holdings has 30,737,797 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding30,737,797
Owned by Insiders―
Owned by Institutions1.03%
Financial Efficiency
Comera Life Sciences Holdings’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee52.76K
Profits Per Employee-1.50M
Employee Count12
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Comera Life Sciences Holdings is ―. Comera Life Sciences Holdings’s PEG ratio is ―.
PE Ratio―
PS Ratio0.01
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Comera Life Sciences Holdings had revenue of 633.10K and earned -18.00M in profits. Earnings per share was -1.76.
Revenue633.10K
Gross Profit422.71K
Operating Income-11.97M
Pretax Income-18.00M
Net Income-18.00M
EBITDA-17.89M
Earnings Per Share (EPS)-1.76
Cash Flow
In the last 12 months, operating cash flow was -6.66M and capital expenditures -28.68M, giving a free cash flow of -35.34M billion.
Operating Cash Flow-6.66M
Free Cash Flow-35.34M
Free Cash Flow per Share-1.15
Dividends & Yields
Comera Life Sciences Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2011.95
52-Week Price Change-75.00%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)4.61K
Important Dates
Comera Life Sciences Holdings upcoming earnings date is Nov 7, 2024, TBA Not Confirmed.
Last Earnings DateAug 8, 2024
Next Earnings DateNov 7, 2024
Ex-Dividend Date―
Financial Position
Comera Life Sciences Holdings as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Comera Life Sciences Holdings has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate―
Enterprise Valuation
Comera Life Sciences Holdings EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Comera Life Sciences Holdings has $1.77M in cash and marketable securities with $271.17K in debt, giving a net cash position of -$1.60M billion.
Cash & Marketable Securities$1.77M
Total Debt$271.17K
Net Cash-$1.60M
Net Cash Per Share-$0.05
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Comera Life Sciences Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―